Zoetis Inc. (NYSE:ZTS) today announced the appointment of Dr. Willie M. Reed, Dean of the College of Veterinary Medicine at Purdue University, to its Board of Directors. Dr. Reed will serve on the Corporate Governance Committee of the Board. Dr. Reed has more than 30 years of experience in animal health and veterinary medicine, gained during his tenure at Purdue University and Michigan State University, and as a Diplomate of the American College of Veterinary Pathologists and Charter Diplomate of the American College of Poultry Veterinarians. Dr. Reed served as president of the Association of American Veterinary Medical Colleges (AAVMC), president of the American Association of Veterinary Laboratory Diagnosticians (AAVLD), president of the American Association of Avian Pathologists (AAAP) and chair of the American Veterinary Medical Association Council on Research. He currently serves on the American Veterinary Medical Association’s (AVMA) Member Services Committee. As a recognized expert in avian pathology, diagnostic medicine and infectious diseases, Dr. Reed brings perspectives on veterinary medicine that will be crucial as Zoetis continues to enhance its reputation as a world leader in animal health. He will add valuable scientific expertise to the Zoetis Board, as well as a unique understanding of the needs of Zoetis customers and the animals that depend on the company’s medicines and vaccines. About Zoetis Zoetis (zô-EH-tis) is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 60 years of experience in animal health, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services. In 2013, the company generated annual revenue of $4.6 billion. With approximately 9,800 employees worldwide at the beginning of 2014, Zoetis has a local presence in approximately 70 countries, including 28 manufacturing facilities in 11 countries. Its products serve veterinarians, livestock producers and people who raise and care for farm and companion animals in 120 countries. For more information, visit www.zoetis.com. DISCLOSURE NOTICES Forward-Looking Statements : This press release may contain forward-looking statements, which reflect Zoetis's current views with respect to business plans or prospects, future operating or financial performance, expectations regarding, indebtedness, future use of cash and dividend payments, and other future events. These statements are not guarantees of future performance or actions. Forward-looking statements are subject to risks and uncertainties. If one or more of these risks or uncertainties materialize, or if management's underlying assumptions prove to be incorrect, actual results may differ materially from those contemplated by a forward-looking statement. Forward-looking statements speak only as of the date on which they are made. Zoetis expressly disclaims any obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. A further list and description of risks, uncertainties and other matters can be found in our Annual Report on Form 10-K for the fiscal year ended December 31, 2012, including in the sections thereof captioned “Forward-Looking Information and Factors That May Affect Future Results” and “Item 1A. Risk Factors,” in our Quarterly Reports on Form 10-Q and in our Current Reports on Form 8-K. These filings and subsequent filings are available online at www.sec.gov , www.zoetis.com , or on request from Zoetis.